Evidence map›Paper›PMID 32306491›Full record

ReviewJournal of cardiac surgery2020

Cardiac involvement in COVID-19 patients: Risk factors, predictors, and complications: A review.

Ghazal Aghagoli, Benjamin Gallo Marin, Luke B Soliman, Frank W Sellke

Open access · greenAbstract readReview
In one paragraph

Review in Journal of cardiac surgery, 2020. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 93 papers, 4 of them syntheses that pooled it.

0numbers the graph read from it
0cells of the map it votes in
93citing papers in PubMed, 4 pooled it
4.3field-weighted citation impact, top 4% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

93 citing papers in PubMed, 4 syntheses or guidelines pooled it, 190 citations in OpenAlex.

  1. Pooled it
  2. Pooled it
  3. Pooled it
  4. Pooled it
  5. Article
  6. Article
  7. Review
  8. Review
  9. Article
  10. Review
  11. Article
  12. Article
  13. Avascular Necrosis of the Hip after the COVID-19 Pandemic.Journal of pharmacy & bioallied sciences · 2023
    Article
  14. Article
  15. Article
  16. Article
  17. Review
  18. Article
  19. Article
  20. Article

33 more citing papers are in PubMed but not listed here.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

4 authors at 1 institution in 1 country.

Ghazal AghagoliWarren Alpert Medical School of Brown University, Providence, Rhode Island.
Benjamin Gallo MarinWarren Alpert Medical School of Brown University, Providence, Rhode Island.ORCID http://orcid.org/0000-0003-4877-354X
Luke B SolimanWarren Alpert Medical School of Brown University, Providence, Rhode Island.ORCID http://orcid.org/0000-0002-3397-603X
Frank W SellkeWarren Alpert Medical School of Brown University, Providence, Rhode Island.ORCID http://orcid.org/0000-0002-8886-801X
Brown University · US

Funding

Effect of Cardioplegia and Cardiopulmonary Bypass on Coronary Microvascular ReactivityR01HL046716 · NHLBI · RHODE ISLAND HOSPITAL · PI SELLKE, FRANK W · 1997 to 2023
$8.5M
Vascular Dysfunction in Myocardial Ischemia and Metabolic SyndromeR01HL128831 · NHLBI · RHODE ISLAND HOSPITAL · PI SELLKE, FRANK W, USHEVA-SIMIDJIYSKA, ANNY · 2016 to 2025
$5.7M
NHLBI NIH HHS R01 HL046716NHLBI NIH HHS R01 HL128831NHLBI NIH HHS R01 HL46716NHLBI NIH HHS RO1 HL128831
6 · The paper itself

Abstract

backgroundRespiratory complications have been well remarked in the novel coronavirus disease (SARS-CoV-2/COVID-19), yet an emerging body of research indicates that cardiac involvement may be implicated in poor outcomes for these patients.

aimsThis review seeks to gather and distill the existing body of literature that describes the cardiac implications of COVID-19. MATERIALS AND

methodsThe English literature was reviewed for papers dealing with the cardiac effects of COVID-19.

resultsNotably, COVID-19 patients with pre-existing cardiovascular disease are counted in greater frequency in intensive care unit settings, and ultimately suffer greater rates of mortality. Other studies have noted cardiac presentations for COVID-19, rather than respiratory, such as acute pericarditis and left ventricular dysfunction. In some patients there has been evidence of acute myocardial injury, with correspondingly increased serum troponin I levels. With regard to surgical interventions, there is a dearth of data describing myocardial protection during cardiac surgery for COVID-19 patients. Although some insights have been garnered in the study of cardiovascular diseases for these patients, these insights remain fragmented and have yet to cement clear guidelines for actionable clinical practice.

conclusionWhile some information is available, further studies are imperative for a more cohesive understanding of the cardiac pathophysiology in COVID-19 patients to promote more informed treatment and, ultimately, better clinical outcomes.

Indexed as

Cause of DeathBetacoronavirusCardiovascular DiseasesComorbidityCoronavirus InfectionsCOVID-19Disease OutbreaksFemaleGlobal HealthHumansMalePandemicsPneumonia, ViralPrevalenceRisk AssessmentSARS-CoV-2cardiac surgeryCOVID-19heartrespiratory failurevirus

Identifiers

PMID32306491
PMCPMC7264604
OpenAlexW3016388920

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.